Immunotherapy Clinical Trial Gives Hope for Rare Skin Cancer
A participant in an immunotherapy clinical trial offered by NYU Langone’s Perlmutter Cancer Center shares her experience.
Immunotherapy Does Not Increase Risk for Prostate Cancer
Transplant recipients can be safely screened and managed for prostate cancer under general guidelines, reports NYU Langone’s Dr. Herbert Lepor.
Immunotherapy Drug Proves Effective for Treating Melanoma
NYU Langone’s Dr. Jeffrey Weber explains to CBS News how one immunotherapy drug is better than another in treating advanced melanoma.
Immunotherapy Helps Lung Cancer Patients Live Longer
NYU Langone researcher Dr. Leena Gandhi leads a study suggesting immunotherapy should be the new standard of care to treat lung cancer.
Immunotherapy Not Yet Effective for All People with Cancer
NYU Langone expert Dr. Vamsidhar Velcheti explains why immunotherapy isn’t effective for all people with cancer and how that could change.
Immunotherapy Provides New Options for Advanced Cancers
NYU Langone researchers pioneer practice-changing advances in immunotherapy for lymphoma, melanoma, and bladder, breast, and lung cancers.
Immunotherapy Trial Prevents Recurrence of Esophageal Cancer
NYU Langone medical oncologist Dr. Deirdre Cohen discusses one patient’s success story after participating in an immunotherapy clinical trial.
Impact of COVID-19 on States’ Fertility Rates Varied Widely
NYU Langone study explored state-level fertility rates after the first two waves of the coronavirus pandemic.
Impaired and facilitated functional networks in temporal lobe epilepsy
NeuroImage: Clinical 2 (2013) 862–872 Contents lists available at SciVerse ScienceDirect NeuroImage: ...
Implantable Brain Device Relieves Pain in Early Study
NYU Langone researchers show brain implant device relieves short-term and chronic pain in rodents.